CJC-1295 With DAC 2mg | Research Peptide
CJC-1295 With DAC 2mg is a synthetic peptide widely studied in growth hormone signaling and cellular research models. The DAC (Drug Affinity Complex) modification is designed to increase peptide stability and half-life in laboratory settings, making it a commonly referenced compound in controlled experimental research.
⚠️ For research use only. Not intended for human or animal consumption.
⸻
What is CJC-1295 With DAC?
CJC-1295 With DAC is a modified growth hormone-releasing hormone (GHRH) analogue developed for scientific research on endocrine signaling pathways. In laboratory studies, it is investigated for its interaction with growth hormone receptors and controlled peptide activity under experimental conditions.
⸻
Key Research Characteristics
•Synthetic GHRH analogue for laboratory research
•DAC modification enhances peptide stability in experimental models
•Studied in growth hormone and endocrine signaling pathways
•Supplied in 2mg lyophilized (freeze-dried) form
•High-purity peptide suitable for analytical and experimental research

Reviews
There are no reviews yet.